From: The treatment and survival of patients with triple negative breast cancer in a London population
Number and % of patients receiving treatment | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
TNBC | Non-TNBC | Unadjusted | Adjusted for age, stage and socioeconomic deprivation | |||||||
N | (%) | n | (%) | OR | (95% CI) | p | OR | (95% CI) | p | |
Treatment | ||||||||||
Surgery | 86 | (67) | 747 | (68) | 0.97 | (0.66, 1.43) | 0.869 | 1.05 | (0.68, 1.62) | 0.815 |
Chemotherapy | 80 | (63) | 293 | (27) | 4.59 | (3.13, 6.73) | <0.001 | 4.21 | (2.63, 6.75) | <0.001 |
Surgery & chemotherapy | 53 | (41) | 208 | (19) | 3.03 | (2.07, 4.44) | <0.001 | 2.52 | (1.61, 3.93) | <0.001 |
Radiotherapy | 20 | (16) | 249 | (23) | 0.63 | (0.38, 1.04) | 0.072 | 0.71 | (0.42, 1.19) | 0.194 |
Hormone therapy | 3 | (2) | 433 | (39) | 0.04 | (0.01, 0.12) | <0.001 | 0.04 | (0.01, 0.12) | <0.001 |